Table 2 Surgical outcomes and final pathologic analysis in patients with and without parametrial involvement
Parametrial invasion | No parametrial invasion | p value | |
|---|---|---|---|
n = 28 (10.6) | n = 235 (89.4) | ||
Surgical approach | 0.02 | ||
Laparoscopy | 16 (57.1) | 141 (60) | |
Laparotomy | 10(35.7) | 32 (13.6) | |
Other (robotic, vaginal) | 2 (7.1) | 36 (15.3) | |
Type of radical surgery | 0.23 | ||
Hysterectomy | 28 (100) | 216 (91.9) | |
Trachelectomy | 0 | 19 (8.1) | |
Pelvic and/or para-aortic lymphadenectomy | 24 (85.7) | 211 (89.8) | 0.5 |
Total number of peroperative complications | 6 (21.4) | 19 (8.1) | 0.03 |
Total number of postoperative complications | 6 (21.4) | 41 (17.4) | 0.6 |
Number of severe postoperative complications (Clavien-Dindo ≥ 3) | 3 (10.7) | 12 (5.1) | 0.2 |
Peritoneal cytology | < 0.001 | ||
Negative | 18 (64.3) | 214 (91.1) | |
Positive | 3 (10.7) | 0 | |
Tumor size (mm) | |||
≤ 30 | 11 (39.3) | 214 (91.1) | < 0.001 |
> 30 | 17 (60.7) | 21 (8.9) | |
Positive margins | < 0.001 | ||
Yes | 11 (39.3) | 6 (2.6) | |
No | 13 (46.4) | 225 (95.7) | |
Lymphovascular space invasion | < 0.001 | ||
Present | 23 (82.1) | 45 (19.1) | |
Absent | 4 (14.3) | 190 (80.9) | |
Lymph node involvement | < 0.001 | ||
Yes | 8 (28.6) | 18 (7.7) | |
No | 18 (64.3) | 217 (92.3) | |